Australia Stock Exchange release from MEMPHASYS : First Felix System commercial sale for clinical IVF use
20/12/2021 24:00
Australia Stock Exchange release from MEMPHASYS MEM.AX : First Felix System commercial sale for clinical IVF use
Recent news on Memphasys
See all newsBrief: Memphasys Receives A$3.5 Million From Peters Investments
Brief: Memphasys Says Potential Expedited FDA Pathway To US IVF Market
Brief: Memphasys Secures 3-Year Felix Agreement With Invido For A$674,000 Minimum Purchases
Australia's Memphasys soars on signing exclusive commercialisation agreement with NOVIVITAE
Brief: Memphasys Says Vietnamese Registration For Felix System Has Been Achieved In August 2026